Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-22 Sale |
2024-03-22 5:06 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
46,938 | $0 | $0 | 0 (Direct) |
View |
| 2024-03-22 Sale |
2024-03-22 5:03 pm |
CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer |
20,125 | $0 | $0 | 0 (Direct) |
View |
| 2024-03-22 Sale |
2024-03-22 5:02 pm |
CymaBay Therapeutics Inc. | CBAY | Dickinson Klara Chief Regulatory Officer |
21,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-03-22 Sale |
2024-03-22 4:59 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
70,262 | $0 | $0 | 0 (Direct) |
View |
| 2024-03-22 Sale |
2024-03-22 4:55 pm |
CymaBay Therapeutics Inc. | CBAY | Wills Robert James Director |
30,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-03-22 Sale |
2024-03-22 4:55 pm |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
406,670 | $0 | $0 | 0 (Direct) |
View |
| 2024-03-22 Sale |
2024-03-22 4:51 pm |
CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director |
90,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 6:43 pm |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
6,000 | $31.97 | $191,849 | 55,000 (Direct) |
View |
| 2024-01-19 Sale |
2024-01-22 6:59 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
18,403 | $23.67 | $435,645 | 446,597 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-16 7:07 pm |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
10,000 | $23.58 | $235,806 | 135,109 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-16 7:07 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $23.58 | $117,898 | 107,000 (Direct) |
View |
| 2024-01-10 Sale |
2024-01-10 8:35 pm |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
6,000 | $23.86 | $143,144 | 61,000 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-18 8:04 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
11,332 | $21.48 | $243,441 | 15,000 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-15 4:38 pm |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
21,497 | $21.99 | $472,646 | 145,109 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-15 4:35 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $21.98 | $109,903 | 112,000 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-11 7:03 pm |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,865 | $20 | $1,297,170 | 171,301 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-11 7:01 pm |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
6,000 | $20.07 | $120,422 | 67,000 (Direct) |
View |
| 2023-11-17 Sale |
2023-11-17 5:58 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
11,342 | $18.28 | $207,293 | 26,332 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-17 5:57 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $17.38 | $86,889 | 117,000 (Direct) |
View |
| 2023-11-13 Sale |
2023-11-14 6:00 pm |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,863 | $15.89 | $1,030,660 | 236,166 (Direct) |
View |
| 2023-11-10 Sale |
2023-11-14 5:56 pm |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
7,000 | $15.24 | $106,700 | 73,000 (Direct) |
View |
| 2023-10-18 Sale |
2023-10-18 6:22 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,743 | $14.07 | $305,941 | 37,674 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
1 | $2.94 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
14,372 | $8.43 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
11,649 | $10 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
52,084 | $1.72 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
18,899 | $9.21 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
22,076 | $4.05 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
3,125 | $11.69 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
2,288 | $5.78 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A 2025-01-06 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
139,119 | $0 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
14,625 | $1.06 | 455,314 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:02 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
41,824 | $7.89 | 79,134 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:02 pm |
N/A 2030-10-11 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
41,824 | $0 | 79,134 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:43 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
6,000 | $4.63 | 55,000 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:43 pm |
N/A 2031-04-04 |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
6,000 | $0 | 55,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:33 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer |
94,875 | $0 | 94,875 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:30 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Dickinson Klara Chief Regulatory Officer |
99,000 | $0 | 99,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:29 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
150,563 | $0 | 165,563 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:28 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
134,063 | $0 | 134,063 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:27 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
453,750 | $0 | 625,051 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:20 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Wills Robert James Director |
14,010 | $0 | 14,010 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:19 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
14,010 | $0 | 14,010 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:18 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director |
14,010 | $0 | 14,010 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:17 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Loewy Caroline M Director |
14,010 | $0 | 14,010 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:16 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | Lefebvre Eric Director |
14,010 | $0 | 14,010 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 6:10 pm |
N/A 2034-01-23 |
CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director |
14,010 | $0 | 14,010 (Direct) |
View |
| 2024-01-19 Exercise |
2024-01-22 6:59 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
1,916 | $1.82 | 446,597 (Direct) |
View |
| 2024-01-19 Exercise |
2024-01-22 6:59 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
8,334 | $10 | 446,597 (Direct) |
View |
| 2024-01-19 Exercise |
2024-01-22 6:59 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
2,778 | $1.72 | 446,597 (Direct) |
View |
| 2024-01-19 Exercise |
2024-01-22 6:59 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
3,125 | $11.69 | 446,597 (Direct) |
View |
| 2024-01-19 Exercise |
2024-01-22 6:59 pm |
N/A 2026-01-25 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
18,403 | $0 | 446,597 (Direct) |
View |
| 2024-01-19 Exercise |
2024-01-22 6:59 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
2,250 | $1.06 | 446,597 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-16 7:07 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
10,000 | $4.05 | 135,109 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-16 7:07 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
10,000 | $0 | 135,109 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-16 7:07 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $2.94 | 107,000 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-16 7:07 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $0 | 107,000 (Direct) |
View |
| 2024-01-10 Exercise |
2024-01-10 8:35 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
6,000 | $4.63 | 61,000 (Direct) |
View |
| 2024-01-10 Exercise |
2024-01-10 8:35 pm |
N/A 2031-04-04 |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
6,000 | $0 | 61,000 (Direct) |
View |
| 2023-12-18 Exercise |
2023-12-18 8:04 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
11,332 | $5 | 15,000 (Direct) |
View |
| 2023-12-18 Exercise |
2023-12-18 8:04 pm |
N/A 2023-12-22 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
11,332 | $0 | 15,000 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-15 4:38 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
11,497 | $8.43 | 145,109 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-15 4:38 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
10,000 | $4.05 | 145,109 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-15 4:38 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
21,497 | $0 | 145,109 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-15 4:35 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $2.94 | 112,000 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-15 4:35 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $0 | 112,000 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-11 7:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,865 | $5 | 171,301 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-11 7:03 pm |
N/A 2023-12-22 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,865 | $0 | 171,301 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-11 7:01 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
6,000 | $4.63 | 67,000 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-11 7:01 pm |
N/A 2031-04-04 |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
6,000 | $0 | 67,000 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-17 5:58 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
11,342 | $5 | 26,332 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-17 5:58 pm |
N/A 2023-12-22 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
11,342 | $0 | 26,332 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 5:57 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
17,500 | $3.45 | 0 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 5:57 pm |
N/A 2027-05-02 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
17,500 | $0 | 0 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 5:57 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $2.94 | 117,000 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 5:57 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $0 | 117,000 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 6:00 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,863 | $5 | 236,166 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 6:00 pm |
N/A 2023-12-22 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,863 | $0 | 236,166 (Direct) |
View |
| 2023-11-10 Exercise |
2023-11-14 5:56 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
7,000 | $4.63 | 73,000 (Direct) |
View |
| 2023-11-10 Exercise |
2023-11-14 5:56 pm |
N/A 2031-04-04 |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
7,000 | $0 | 73,000 (Direct) |
View |
| 2023-10-18 Exercise |
2023-10-18 6:22 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,743 | $5 | 37,674 (Direct) |
View |
| 2023-10-18 Exercise |
2023-10-18 6:22 pm |
N/A 2023-10-30 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,743 | $0 | 37,674 (Direct) |
View |